Recent advances in drug delivery systems for targeting cancer stem cells

2019

2020

Hidalgo, 2010, Pancreatic cancer, N Engl J Med, 362, 1605, 10.1056/NEJMra0901557

Chang, 2016, Cancer stem cells: role in tumor growth, recurrence, metastasis, and treatment resistance, Medicine, 95, S20, 10.1097/MD.0000000000004766

Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167

Zhao, 2018, Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies, Semin Canc Biol, 53, 139, 10.1016/j.semcancer.2018.08.002

Chen, 2013, Understanding and targeting cancer stem cells: therapeutic implications and challenges, Acta Pharmacol Sin, 34, 732, 10.1038/aps.2013.27

Paget, 1889, The distribution of secondary growths in cancer of the breast, Lancet, 133, 571, 10.1016/S0140-6736(00)49915-0

Lau, 2017, Cancer stem cells and their microenvironment: biology and therapeutic implications, Stem Cell Int, 2017, 3714190

Plaks, 2015, The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?, Cell stem cell, 16, 225, 10.1016/j.stem.2015.02.015

Adjei, 2015, Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach, J Funct Biomater, 6, 81, 10.3390/jfb6010081

Kirtane, 2013, Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities, Adv Drug Deliv Rev, 65, 1731, 10.1016/j.addr.2013.09.001

Iyer, 2013, Role of integrated cancer nanomedicine in overcoming drug resistance, Adv Drug Deliv Rev, 65, 1784, 10.1016/j.addr.2013.07.012

Pattabiraman, 2014, Tackling the cancer stem cells—what challenges do they pose?, Nat Rev Drug Discov, 13, 497, 10.1038/nrd4253

Putzer, 2017, Advances in cancer stem cell targeting: how to strike the evil at its root, Adv Drug Deliv Rev, 120, 89, 10.1016/j.addr.2017.07.013

Bidram, 2019, A concise review on cancer treatment methods and delivery systems, J Drug Deliv Sci Technol, 54, 101350, 10.1016/j.jddst.2019.101350

Jimenez-Lopez, 2019, A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer, Pharmacol Res, 141, 451, 10.1016/j.phrs.2019.01.013

van Uden, 2020, Better survival after surgery of the primary tumor in stage IV inflammatory breast cancer, Surg Oncol, 33, 43, 10.1016/j.suronc.2020.01.005

Gelatti, 2019, Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC), Lung Canc, 137, 113, 10.1016/j.lungcan.2019.09.017

Hermawan, 2018, Current report of natural product development against breast cancer stem cells, Int J Biochem Cell Biol, 104, 114, 10.1016/j.biocel.2018.09.012

Cianciosi, 2018, Targeting molecular pathways in cancer stem cells by natural bioactive compounds, Pharmacol Res, 135, 150, 10.1016/j.phrs.2018.08.006

Lv, 2015, Existing drugs and their application in drug discovery targeting cancer stem cells, Arch Pharm Res (Seoul), 38, 1617, 10.1007/s12272-015-0628-1

Dianat-Moghadam, 2018, Cancer stem cells-emanated therapy resistance: implications for liposomal drug delivery systems, J Contr Release, 288, 62, 10.1016/j.jconrel.2018.08.043

Shen, 2015, Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells, Theranostics, 5, 755, 10.7150/thno.10804

Yi, 2019, Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells, J Contr Release, 295, 268, 10.1016/j.jconrel.2019.01.006

Ning, 2016, Targeting colorectal cancer stem-like cells with anti-CD133 antibody-conjugated SN-38 nanoparticles, ACS Appl Mater Interfaces, 8, 17793, 10.1021/acsami.6b04403

Tan, 2018, Apoferritin nanocages loading mertansine enable effective eradiation of cancer stem-like cells in vitro, Int J Pharm, 553, 201, 10.1016/j.ijpharm.2018.10.038

Wang, 2011, Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy, Nano Lett, 11, 772, 10.1021/nl103992v

Lopez-Bertoni, 2018, Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell regulating miRNAs inhibit glioblastoma growth and prolong survival, Nano Lett, 18, 4086, 10.1021/acs.nanolett.8b00390

Ren, 2016, Sequential co-delivery of miR-21 inhibitor followed by burst release doxorubicin using NIR-responsive hollow gold nanoparticle to enhance anticancer efficacy, J Contr Release, 228, 74, 10.1016/j.jconrel.2016.03.008

Yang, 2017, pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells, Biomaterials, 147, 53, 10.1016/j.biomaterials.2017.09.013

Najafi, 2019, Cancer stem cell (a) symmetry & plasticity: tumorigenesis and therapy relevance, Life Sci, 231, 116520, 10.1016/j.lfs.2019.05.076

Borovski, 2011, Cancer stem cell niche: the place to be, Can Res, 71, 634, 10.1158/0008-5472.CAN-10-3220

Hiratsuka, 2006, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat Cell Biol, 8, 1369, 10.1038/ncb1507

Tang, 2012, Understanding cancer stem cell heterogeneity and plasticity, Cell Res, 22, 457, 10.1038/cr.2012.13

Boesch, 2016, Heterogeneity of cancer stem cells: rationale for targeting the stem cell niche, Biochim Biophys Acta, 1866, 276

Malanchi, 2011, Interactions between cancer stem cells and their niche govern metastatic colonization, Nature, 481, 85, 10.1038/nature10694

Garcia-Mazas, 2017, Biomaterials to suppress cancer stem cells and disrupt their tumoral niche, Int J Pharm, 523, 490, 10.1016/j.ijpharm.2016.12.013

Das, 2008, Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction, Stem Cell, 26, 1818, 10.1634/stemcells.2007-0724

Dimou, 2012, Overcoming the stromal barrier: technologies to optimize drug delivery in pancreatic cancer, Ther Adv Med Oncol, 4, 271, 10.1177/1758834012446008

Usacheva, 2014, Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles, Mol Pharm, 11, 3186, 10.1021/mp5003619

Wang, 2020, Nanoparticles-mediated reoxygenation strategy relieves tumor hypoxia for enhanced cancer therapy, J Contr Release, 319, 25, 10.1016/j.jconrel.2019.12.028

Bradford, 1997, Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment, Exp Hematol, 25, 445

Chiou, 2012, Cationic polyurethanes-short branch PEI-mediated delivery of mir 145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma, J Contr Release, 159, 240, 10.1016/j.jconrel.2012.01.014

Ahmad, 2016, Development of liposomal formulation for delivering anticancer drug to breast cancer stem-cell-like cells and its pharmacokinetics in an animal model, Mol Pharm, 13, 1081, 10.1021/acs.molpharmaceut.5b00900

Shukla, 2014, Epigenetics of cancer stem cells: pathways and therapeutics, Biochim Biophys Acta, 1840, 3494, 10.1016/j.bbagen.2014.09.017

Takebe, 2015, Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update, Nat Rev Clin Oncol, 12, 445, 10.1038/nrclinonc.2015.61

Karandish, 2018, Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors, Colloids Surf B Biointerfaces, 163, 225, 10.1016/j.colsurfb.2017.12.036

Liu, 2015, Delivery of mitogen-activated protein kinase inhibitor for hepatocellular carcinoma stem cell therapy, ACS Appl Mater Interfaces, 7, 1012, 10.1021/am508262j

Miller-Kleinhenz, 2018, Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer, Biomaterials, 152, 47, 10.1016/j.biomaterials.2017.10.035

Pindiprolu, 2019, CD133 receptor mediated delivery of STAT3 inhibitor for simultaneous elimination of cancer cells and cancer stem cells in oral squamous cell carcinoma, Med Hypotheses, 129, 109241, 10.1016/j.mehy.2019.109241

Li, 2019, The delivery of a Wnt pathway inhibitor toward CSCs requires stable liposome encapsulation and delayed drug release in tumor tissues, Mol Ther, 27, 1558, 10.1016/j.ymthe.2019.06.013

Shen, 2015, Delivery of bortezomib with nanoparticles for basal-like triple-negative breast cancer therapy, J Contr Release, 208, 14, 10.1016/j.jconrel.2014.12.043

Kaushik, 2016, Low doses of PEG-coated gold nanoparticles sensitize solid tumors to cold plasma by blocking the PI3K/AKT-driven signaling axis to suppress cellular transformation by inhibiting growth and EMT, Biomaterials, 87, 118, 10.1016/j.biomaterials.2016.02.014

Satapathy, 2018, Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner, Nanomedicine, 14, 883, 10.1016/j.nano.2018.01.007

Zuo, 2016, Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-beta signaling pathway inhibition, Biomaterials, 82, 48, 10.1016/j.biomaterials.2015.12.014

Rafael, 2018, AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells, Drug Deliv, 25, 961, 10.1080/10717544.2018.1461276

Basak, 2015, Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells, Oncotarget, 6, 18504, 10.18632/oncotarget.4181

Mamaeva, 2016, Inhibiting Notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying gamma-secretase Inhibitors, Mol Ther, 24, 926, 10.1038/mt.2016.42

Suh, 2017, Control of cancer stem cell like population by intracellular target identification followed by the treatment with peptide-siRNA complex, Biochem Biophys Res Commun, 491, 827, 10.1016/j.bbrc.2017.05.148

Wang, 2015, miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells, Oncotarget, 6, 37852, 10.18632/oncotarget.5635

Goodman, 2007, Increased nanoparticle penetration in collagenase-treated multicellular spheroids, Int J Nanomed, 2, 265

Chen, 2016, Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system, J Contr Release, 241, 68, 10.1016/j.jconrel.2016.09.014

Zhou, 2020, Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer, Acta Pharm Sin B, 10, 1563, 10.1016/j.apsb.2019.11.013

Woodward, 2008, Cancer stem cells:markers or biomarkers?, Canc Metastasis Rev, 27, 459, 10.1007/s10555-008-9130-2

Mokhtarzadeh, 2017, Nano-delivery system targeting to cancer stem cell cluster of differentiation biomarkers, J Contr Release, 266, 166, 10.1016/j.jconrel.2017.09.028

Shen, 2016, Nanomedicine-mediated cancer stem cell therapy, Biomaterials, 74, 1, 10.1016/j.biomaterials.2015.09.037

Kim, 2019, Anti-MUC1–CD44 dual-aptamer-conjugated liposomes for cotargeting breast cancer cells and cancer stem cells, ACS Appl. Bio Mater, 2, 4622, 10.1021/acsabm.9b00705

Leite Nascimento, 2016, Hyaluronic acid-conjugated lipoplexes for targeted delivery of siRNA in a murine metastatic lung cancer model, Int J Pharm, 514, 103, 10.1016/j.ijpharm.2016.06.125

Debele, 2018, pH- and GSH-Sensitive hyaluronic acid-MP conjugate micelles for intracellular delivery of doxorubicin to colon cancer cells and cancer stem cells, Biomacromolecules, 19, 3725, 10.1021/acs.biomac.8b00856

Arabi, 2015, Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin, J Contr Release, 220, 275, 10.1016/j.jconrel.2015.10.044

Yao, 2014, The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells, Biomaterials, 35, 9208, 10.1016/j.biomaterials.2014.07.033

Wang, 2013, The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel, Biomaterials, 34, 7662, 10.1016/j.biomaterials.2013.06.042

Han, 2016, Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells, Int J Nanomed, 11, 1413, 10.2147/IJN.S95850

Li, 2018, Specific cancer stem cell-therapy by albumin nanoparticles functionalized with CD44-mediated targeting, J Nanobiotechnol, 16, 99, 10.1186/s12951-018-0424-4

Kesharwani, 2015, Hyaluronic acid engineered nanomicelles loaded with 3,4-difluorobenzylidene curcumin for targeted killing of CD44+ stem-like pancreatic cancer cells, Biomacromolecules, 16, 3042, 10.1021/acs.biomac.5b00941

Wang, 2016, Combined cancer therapy with hyaluronan-decorated fullerene-silica multifunctional nanoparticles to target cancer stem-like cells, Biomaterials, 97, 62, 10.1016/j.biomaterials.2016.04.030

Wang, 2015, Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells, Biomaterials, 72, 74, 10.1016/j.biomaterials.2015.08.048

Li, 2019, In vivo beta-catenin attenuation by the integrin alpha5-targeting nano-delivery strategy suppresses triple negative breast cancer stemness and metastasis, Biomaterials, 188, 160, 10.1016/j.biomaterials.2018.10.019

Li, 2019, Nucleus-targeted nano delivery system eradicates cancer stem cells by combined thermotherapy and hypoxia-activated chemotherapy, Biomaterials, 200, 1, 10.1016/j.biomaterials.2019.01.048

Huang, 2017, Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells, World J Surg Oncol, 15, 167, 10.1186/s12957-017-1230-4

Xiang, 2017, Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery, Theranostics, 7, 4071, 10.7150/thno.20168

Shi, 2017, Enhancing the anti-multiple myeloma efficiency in a cancer stem cell xenograft model by conjugating the ABCG2 antibody with microbubbles for a targeted delivery of ultrasound mediated epirubicin, Biochem Pharmacol, 132, 18, 10.1016/j.bcp.2017.02.014

Liang, 2015, CD44v6 monoclonal antibody-conjugated gold nanostars for targeted photoacoustic imaging and plasmonic photothermal therapy of gastric cancer stem-like cells, Theranostics, 5, 970, 10.7150/thno.11632

Li, 2017, Polymer–lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells, Int J Nanomed, 12, 6909, 10.2147/IJN.S144184

Zeng, 2018, Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells, Acta Pharmacol Sin, 39, 261, 10.1038/aps.2017.166

Sun, 2014, Using SV119-gold nanocage conjugates to eradicate cancer stem cells through a combination of photothermal and chemo therapies, Adv Healthc Mater, 3, 1283, 10.1002/adhm.201400026

Qiao, 2016, A novel double-targeted nondrug delivery system for targeting cancer stem cells, Int J Nanomed, 11, 6667, 10.2147/IJN.S116230

Li, 2016, Multifunctional “core-shell” nanoparticles-based gene delivery for treatment of aggressive melanoma, Biomaterials, 111, 124, 10.1016/j.biomaterials.2016.09.019

Chen, 2018, Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells, Nanomedicine, 14, 2115, 10.1016/j.nano.2018.05.015

Heldin, 2020, Involvement of hyaluronan and CD44 in cancer and viral infections, Cell Signal, 65, 109427, 10.1016/j.cellsig.2019.109427

Miyano, 2017, cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells, J Contr Release, 261, 275, 10.1016/j.jconrel.2017.06.021

Ahmad, 2017, Cancer stem cell-targeted therapeutics and delivery strategies, Expet Opin Drug Deliv, 14, 997, 10.1080/17425247.2017.1263615

Sun, 2014, Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds, Biomaterials, 35, 836, 10.1016/j.biomaterials.2013.10.011

Wang, 2014, Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells, ACS Nano, 8, 12151, 10.1021/nn503491e

Zhao, 2020, Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles, Nanomedicine, 24, 102124, 10.1016/j.nano.2019.102124

Du, 2011, Tailor-made dual pH-sensitive polymer‒doxorubicin nanoparticles for efficient anticancer drug delivery, J Am Chem Soc, 133, 17560, 10.1021/ja207150n

Chen, 2016, Enhanced sensitivity of cancer stem cells to chemotherapy using functionalized mesoporous silica nanoparticles, Mol Pharm, 13, 2749, 10.1021/acs.molpharmaceut.6b00352

Schonberg David, 2015, Preferential iron trafficking characterizes glioblastoma stem-like cells, Canc Cell, 28, 441, 10.1016/j.ccell.2015.09.002

Galluzzi, 2014, Metabolic control of autophagy, Cell, 159, 1263, 10.1016/j.cell.2014.11.006

Lei, 2017, Targeting autophagy in cancer stem cells as an anticancer therapy, Canc Lett, 393, 33, 10.1016/j.canlet.2017.02.012

Nazio, 2019, Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications, Cell Death Differ, 26, 690, 10.1038/s41418-019-0292-y

Liang, 2016, The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair, Canc Lett, 376, 249, 10.1016/j.canlet.2016.04.002

Pelt, 2018, Chloroquine and nanoparticle drug delivery: a promising combination, Pharmacol Ther, 191, 43, 10.1016/j.pharmthera.2018.06.007

Joshi, 2012, The anticancer activity of chloroquine-gold nanoparticles against MCF-7 breast cancer cells, Colloids Surf B Biointerfaces, 95, 195, 10.1016/j.colsurfb.2012.02.039

Sun, 2016, Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells, Biomaterials, 103, 44, 10.1016/j.biomaterials.2016.06.038

Fakhrejahani, 2015, Immunotherapies for bladder cancer: a new hope, Curr Opin Urol, 25, 586, 10.1097/MOU.0000000000000213

Liu, 2018, An immunological storm for cancer therapy: 2018 Nobel Prize in Physiology or Medicine, Sci Bull, 63, 1608, 10.1016/j.scib.2018.11.023

El-Ashmawy, 2019, A new strategy for enhancing antitumor immune response using dendritic cells loaded with chemo-resistant cancer stem-like cells in experimental mice model, Mol Immunol, 111, 106, 10.1016/j.molimm.2019.04.001

Dashti, 2016, Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses, Canc Lett, 374, 175, 10.1016/j.canlet.2016.01.021

Bourseau-Guilmain, 2012, Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133, Int J Pharm, 423, 93, 10.1016/j.ijpharm.2011.06.001

Folmes, 2016, Mitochondria in pluripotent stem cells: stemness regulators and disease targets, Curr Opin Genet Dev, 38, 1, 10.1016/j.gde.2016.02.001

Xu, 2013, Mitochondrial regulation in pluripotent stem cells, Cell Metabol, 18, 325, 10.1016/j.cmet.2013.06.005

Loureiro, 2017, Mitochondrial biology in cancer stem cells, Semin Canc Biol, 47, 18, 10.1016/j.semcancer.2017.06.012

Skoda, 2019, Pharmacological targeting of mitochondria in cancer stem cells: an ancient organelle at the crossroad of novel anti-cancer therapies, Pharmacol Res, 139, 298, 10.1016/j.phrs.2018.11.020

Zhang, 2012, Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells, Biomaterials, 33, 565, 10.1016/j.biomaterials.2011.09.055

Mignotte, 1998, Mitochondria and apoptosis, Eur J Biochem, 252, 1, 10.1046/j.1432-1327.1998.2520001.x

Ma, 2013, Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes, Biomaterials, 34, 4452, 10.1016/j.biomaterials.2013.02.066

Stratton, 2009, The cancer genome, Nature, 458, 719, 10.1038/nature07943

Mendell Joshua, 2012, MicroRNAs in stress signaling and human disease, Cell, 148, 1172, 10.1016/j.cell.2012.02.005

Dawson, 2012, Cancer epigenetics: from mechanism to therapy, Cell, 150, 12, 10.1016/j.cell.2012.06.013

Nebbioso, 2018, Cancer epigenetics: moving forward, PLoS Genet, 14, 10.1371/journal.pgen.1007362

Dumitrescu, 2012

Sakamoto, 2017, Non-coding RNAs are promising targets for stem cell-based cancer therapy, Noncoding RNA Res, 2, 83, 10.1016/j.ncrna.2017.05.002

Mimeault, 2014, Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies, Mol Aspect Med, 39, 3, 10.1016/j.mam.2013.08.001

Shim, 2010, Efficient and targeted delivery of siRNA in vivo, FEBS J, 277, 4814, 10.1111/j.1742-4658.2010.07904.x

Mirza, 2019, Nanoparticles-based drug delivery and gene therapy for breast cancer: recent advancements and future challenges, Semin Canc Biol, 10.1016/j.semcancer.2019.10.020

Ke, 2018, Delivery of NF-κB shRNA using carbamate-mannose modified PEI for eliminating cancer stem cells, Nanomedicine, 14, 405, 10.1016/j.nano.2017.11.015

Andey, 2019, Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors, Nanomedicine, 18, 31, 10.1016/j.nano.2019.02.007

Mittal, 2014, Efficacy of gemcitabine conjugated and miRNA-205 complexed micelles for treatment of advanced pancreatic cancer, Biomaterials, 35, 7077, 10.1016/j.biomaterials.2014.04.053

Jang, 2016, Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy, Biomaterials, 105, 12, 10.1016/j.biomaterials.2016.07.036

Wen, 2017, Micellar delivery of miR-34a modulator rubone and paclitaxel in resistant prostate cancer, Can Res, 77, 3244, 10.1158/0008-5472.CAN-16-2355

Verma, 2015, Anthothecol-encapsulated PLGA nanoparticles inhibit pancreatic cancer stem cell growth by modulating sonic hedgehog pathway, Nanomedicine, 11, 2061, 10.1016/j.nano.2015.07.001

Andey, 2014, Cationic lipid guided short-hairpin RNA interference of annexin A2 attenuates tumor growth and metastasis in amouse lung cancer stem cell model, J Contr Release, 184, 67, 10.1016/j.jconrel.2014.03.049

Yang, 2018, Enhancing the therapeutic effect via elimination of hepatocellular carcinoma stem cells using Bmi1 siRNA delivered by cationic cisplatin nanocapsules, Nanomedicine, 14, 2009, 10.1016/j.nano.2018.05.012

Yang, 2012, Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI, Biomaterials, 33, 1462, 10.1016/j.biomaterials.2011.10.071

Shin, 2020, Let-7 miRNA and CDK4 siRNA co-encapsulated in Herceptin-conjugated liposome for breast cancer stem cells, Asian J Pharm Sci, 15, 472, 10.1016/j.ajps.2019.03.001

Yang, 2015, Nuclear localization signal-enhanced polyurethane-short branch polyethylenimine-mediated delivery of Let-7a inhibited cancer stem-like properties by targeting the 3′-UTR of HMGA2 in anaplastic astrocytoma, Cell Transplant, 24, 1431, 10.3727/096368914X682107

Liu, 2016, MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell, Int J Nanomed, 11, 6713, 10.2147/IJN.S111647

Yang, 2018, Ultrasound microbubbles mediated miR-let-7b delivery into CD133+ ovarian cancer stem cells, Biosci Rep, 38, 10.1042/BSR20180922

Ma, 2018, Blocking stemness and metastatic properties of ovarian cancer cells by targeting p70S6K with dendrimer nanovector-based siRNA delivery, Mol Ther, 26, 70, 10.1016/j.ymthe.2017.11.006

Caldas, 2005, Sizing up miRNAs as cancer genes, Nat Med, 11, 712, 10.1038/nm0705-712

Garofalo, 2015, Role of microRNAs in maintaining cancer stem cells, Adv Drug Deliv Rev, 81, 53, 10.1016/j.addr.2014.11.014

Oak, 2012, Combinatorial treatment of mammospheres with trastuzumab and salinomycin efficiently targets HER2-positive cancer cells and cancer stem cells, Int J Canc, 131, 2808, 10.1002/ijc.27595

Han, 2013, Cancer stem cells: therapeutic implications and perspectives in cancer therapy, Acta Pharm Sin B, 3, 65, 10.1016/j.apsb.2013.02.006

Zhao, 2016, An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors, Biomaterials, 93, 1, 10.1016/j.biomaterials.2016.03.032

Shen, 2015, Co-delivery of platinum drug and siNotch1 with micelleplex for enhanced hepatocellular carcinoma therapy, Biomaterials, 70, 71, 10.1016/j.biomaterials.2015.08.026

Sun, 2018, Cargo-free nanomedicine with pH sensitivity for codelivery of DOX conjugated prodrug with SN38 to synergistically eradicate breast cancer stem cells, Mol Pharm, 15, 3343, 10.1021/acs.molpharmaceut.8b00367

Sun, 2015, Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells, Biomaterials, 37, 405, 10.1016/j.biomaterials.2014.10.018

Kim, 2015, Co-eradication of breast cancer cells and cancer stem cells by cross-linked multilamellar liposomes enhances tumor treatment, Mol Pharm, 12, 2811, 10.1021/mp500754r

Yang, 2017, Combination therapy of paclitaxel and cyclopamine polymer-drug conjugates to treat advanced prostate cancer, Nanomedicine, 13, 391, 10.1016/j.nano.2016.07.017

Al Faraj, 2016, Combination of drug-conjugated SWCNT nanocarriers for efficient therapy of cancer stem cells in a breast cancer animal model, J Contr Release, 225, 240, 10.1016/j.jconrel.2016.01.053

Tsai, 2019, Dual delivery of HNF4α and cisplatin by mesoporous silica nanoparticles inhibits cancer pluripotency and tumorigenicity in hepatoma-derived CD133-expressing stem cells, ACS Appl Mater Interfaces, 11, 19808, 10.1021/acsami.9b04474

Uz, 2019, Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer, J Contr Release, 294, 237, 10.1016/j.jconrel.2018.12.031

Shi, 2014, Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression, J Contr Release, 194, 228, 10.1016/j.jconrel.2014.09.005

Zhang, 2017, Effective treatment of drug resistant recurrent breast tumors harboring cancer stem-like cells by staurosporine/epirubicin co-loaded polymeric micelles, J Contr Release, 264, 127, 10.1016/j.jconrel.2017.08.025

Zhou, 2013, HPMA copolymer-based combination therapy toxic to both prostate cancer stem/progenitor cells and differentiated cells induces durable anti-tumor effects, J Contr Release, 172, 946, 10.1016/j.jconrel.2013.09.005

Li, 2014, Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma, Biomaterials, 35, 5591, 10.1016/j.biomaterials.2014.03.049

Kinoh, 2016, Nanomedicines eradicating cancer stem-like cells in vivo by pH-triggered intracellular cooperative action of loaded drugs, ACS Nano, 10, 5643, 10.1021/acsnano.6b00900

Zhang, 2012, The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles, Biomaterials, 33, 679, 10.1016/j.biomaterials.2011.09.072

Wu, 2018, Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth, Int J Nanomed, 13, 5405, 10.2147/IJN.S166104

Huang, 2016, Dual drug-loaded biofunctionalized amphiphilic chitosan nanoparticles: enhanced synergy between cisplatin and demethoxycurcumin against multidrug-resistant stem-like lung cancer cells, Eur J Pharm Biopharm, 109, 165, 10.1016/j.ejpb.2016.10.014

Yang, 2014, Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells, Eur J Pharm Biopharm, 88, 737, 10.1016/j.ejpb.2014.10.006

Ke, 2014, Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells, Biomaterials, 35, 1096, 10.1016/j.biomaterials.2013.10.049

Muntimadugu, 2016, CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel, Colloids Surf B Biointerfaces, 143, 532, 10.1016/j.colsurfb.2016.03.075

Lin, 2019, Dual responsive micelles capable of modulating miRNA-34a to combat taxane resistance in prostate cancer, Biomaterials, 192, 95, 10.1016/j.biomaterials.2018.10.036

Fonseca, 2015, Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination, Biomaterials, 69, 76, 10.1016/j.biomaterials.2015.08.007

Guo, 2017, Active targeting co-delivery system based on hollow mesoporous silica nanoparticles for antitumor therapy in ovarian cancer stem-like cells, Oncol Rep, 38, 1442, 10.3892/or.2017.5829

Li, 2019, Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo, Drug Deliv, 26, 794, 10.1080/10717544.2019.1645244

Li, 2017, Codelivery of salinomycin and docetaxel using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells, Anti Canc Drugs, 28, 989, 10.1097/CAD.0000000000000541

Mahira, 2019, Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: a new insight into nanomedicine based combinational chemotherapy for prostate cancer, Biomed Pharmacother, 110, 803, 10.1016/j.biopha.2018.11.145

Liang, 2018, Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy, Colloids Surf B Biointerfaces, 172, 506, 10.1016/j.colsurfb.2018.08.063

Hu, 2015, Hyaluronic acid functional amphipathic and redox-responsive polymer particles for the co-delivery of doxorubicin and cyclopamine to eradicate breast cancer cells and cancer stem cells, Nanoscale, 7, 8607, 10.1039/C5NR01084E

Lang, 2019, Cocktail strategy based on spatio-temporally controlled nano device improves therapy of breast cancer, Adv Mater, 31, 10.1002/adma.201806202

Zhang, 2017, Co-delivery of carboplatin and paclitaxel via cross-linked multilamellar liposomes for ovarian cancer treatment, RSC Adv, 7, 19685, 10.1039/C7RA01100H